Morning Breakouts

Latest KFF Health News Stories

Nearly A Third Of Medicare Beneficiaries Face Steep Premium Increases

Morning Briefing

The announcement about premiums and the lack of a Social Security cost-of-living increase made official what many seniors and politicians had been warning: 30 percent of beneficiaries will see their health insurance premiums soar in 2016. The White House and Congress are contemplating fixes, but the effort is mired in the GOP leadership problems on the Hill and budget talks.

Cigna To Pull Florida Plans From Health Exchange — Just Two Weeks Before Open Enrollment

Morning Briefing

Cigna’s Florida exit will impact 2016 plans that would have been available through the federal exchange starting Nov. 1. Also in the news, Pennsylvania regulators say the cost of premiums for individual health plans will rise in the year ahead; while Connecticut reports that the state’s uninsured rate drops below figures from the U.S. Census.

Urban Hospitals Engage Beyond Medicine In Effort To Address Community Problems

Morning Briefing

In Baltimore, Johns Hopkins University and the Hopkins hospital and health system have begun an initiative to alleviate some poverty and improve health. Meanwhile, in Florida, the University of Central Florida is joining forces with HCA to train doctors in the hope that they will stay in the state. Also in Florida, the future of a key hospital funding program is uncertain.

Advocates Pressing For States To Recognize Dental Therapists To Help Meet Consumer Needs

Morning Briefing

Millions of Americans do not seek dental care, often because they can’t afford it. A new mid-level professional that could handle some of the regular care with less expense, might help. In other consumer health news, some employers are offering cash bonuses to workers who find cheaper medical care, telemedicine is opening some doors and retirement health care can be expensive.

Valeant Pharmaceuticals Under Federal Investigation For Drug Pricing Practices

Morning Briefing

In other news, Bloomberg examines an effort by top cancer hospitals to provide patients with information about the cost of the drugs used in their treatments. Meanwhile, The Wall Street Journal takes a look at Theranos, and The Washington Post reports that a watchdog group has thrown up a red flag regarding the Food and Drug Administration’s review of a blood-thinning drug.